|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.330 USD | -12.50% |
|
-7.64% | -78.27% |
| 06-30 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
| Market Cap | 31.82M 27.91M 25.77M 23.81M 45.13M 3.05B 46.04M 310M 120M 1.49B 119M 117M 5.18B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 31.82M 27.91M 25.77M 23.81M 45.13M 3.05B 46.04M 310M 120M 1.49B 119M 117M 5.18B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
85.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Actuate Therapeutics, Inc.
| 1 day | -12.50% | ||
| 1 week | -7.64% | ||
| Current month | -13.07% | ||
| 1 month | -26.92% | ||
| 3 months | -30.73% | ||
| 6 months | -78.82% | ||
| Current year | -78.27% |
| 1 week | 1.2 |  | 1.57 |
| 1 month | 1.2 | | 2.78 |
| Current year | 1.2 | | 7.05 |
| 1 year | 1.2 | | 9.22 |
| 3 years | 1.2 | | 11.99 |
| 5 years | 1.2 | | 11.99 |
| 10 years | 1.2 | | 11.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
CEO | Chief Executive Officer | 64 | 01/03/2015 |
Paul Lytle
DFI | Director of Finance/CFO | 58 | 01/02/2024 |
Andrew Mazar
COO | Chief Operating Officer | 64 | 01/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Thomson
BRD | Director/Board Member | 65 | 01/09/2022 |
Daniel Schmitt
BRD | Director/Board Member | 64 | 01/04/2015 |
Martin Huber
BRD | Director/Board Member | 66 | 01/05/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-21 | Free | Director | 15,000 | 0.0633% | ||
| 05-21 | Free | Director | 15,000 | 0.0633% | ||
| 05-21 | Free | Director | 15,000 | 0.0633% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.50% | -7.64% | -78.69% | - | 31.82M | |
| -0.08% | -3.22% | +71.74% | +127.13% | 56.71B | |
| -2.45% | -7.83% | +63.92% | +83.15% | 51.3B | |
| +3.27% | +8.91% | +21.21% | +486.76% | 25.26B | |
| -0.81% | -0.42% | -16.24% | -12.47% | 23.65B | |
| +3.93% | +3.35% | +43.09% | -2.47% | 18.69B | |
| -0.22% | +0.59% | +37.44% | -26.22% | 17.71B | |
| +2.34% | +12.50% | +224.02% | +380.99% | 17.7B | |
| -0.92% | +1.58% | +35.79% | - | 14.26B | |
| -1.70% | +3.98% | +28.96% | +190.57% | 14.1B | |
| Average | -0.82% | +2.85% | +43.13% | +153.43% | 23.94B | |
| Weighted average by Cap. | +0.12% | +2.20% | +57.85% | +143.90% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | $1.330 | -12.50% | 212,224 |
| 07/07/26 | $1.520 | +8.57% | 109,485 |
| 06/07/26 | $1.400 | -7.89% | 69,996 |
| 02/07/26 | $1.520 | +5.56% | 179,886 |
| 01/07/26 | $1.440 | -5.88% | 135,777 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.330USD
Average target price
9.978USD
Spread / Average Target
+650.19%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
